Characterization of recombinant and natural forms of the human LIM domain-containing protein FHL2

被引:10
|
作者
El Mourabit, H
Müller, S
Tunggal, L
Paulsson, M
Aumailley, M
机构
[1] Univ Cologne, Ctr Biochem, D-50931 Cologne, Germany
[2] Univ Cologne, Fac Med, Ctr Mol Med, D-50931 Cologne, Germany
关键词
FHL2; LIM domain; baculovirus; MALDI-TOF; mass spectrometry;
D O I
10.1016/S1046-5928(03)00211-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
FHL2 (Four and a Half LIM domain-containing protein 2) is a member of a small family of proteins with four LIM domains and an N-terminal half LIM domain. It is an intracellular protein thought to function as an adaptor in the formation of multi-protein complexes involved in signaling. To obtain human FHL2 in amounts allowing further characterization, we evaluated different expression systems and chose to express FHL2 with a His6 tag in insect cells using the baculovirus system. The recombinant protein was highly expressed and could be purified to >98% homogeneity as judged by SDS-PAGE analysis. Purified recombinant FHL2 was used to generate antibodies allowing detection and immunoprecipitation of FHL2 from human cells. Both recombinant and natural FHL2 were characterized by SDS-PAGE and MALDI-TOF mass spectrometry. The molecular mass of the recombinant His6-tagged protein obtained by mass spectrometry was 36,995 Da, in good agreement with the apparent mass of 36 kDa in SDS-PAGE and slightly higher than the 35,981 Da calculated from the sequence of the construct. The measured molecular mass of natural human FHL2 was 32,742 Da and the calculated mass was 32,192 Da. However, the apparent molecular mass in SDS-PAGE is 41 kDa, indicating that the natural protein has an abnormal electrophoretic mobility. The results show that both the recombinant and the natural proteins are post-translationally modified and indicate that such modifications may lead to an abnormal electrophoretic behavior of natural human FHL2. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:95 / 103
页数:9
相关论文
共 50 条
  • [41] The LIM-only protein, FHL2, suppresses TRAF6-mediated osteoclastogenesis.
    Bai, S
    Chen, J
    Ross, FP
    Teitelbaum, SL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S9 - S9
  • [42] LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells
    Zienert, Elisa
    Eke, Iris
    Aust, Daniela
    Cordes, Nils
    CANCER LETTERS, 2015, 364 (01) : 17 - 24
  • [43] Deficiency of the LIM-Only Protein FHL2 Reduces Intestinal Tumorigenesis in Apc Mutant Mice
    Labalette, Charlotte
    Nouet, Yann
    Levillayer, Florence
    Colnot, Sabine
    Chen, Ju
    Claude, Valere
    Huerre, Michel
    Perret, Christine
    Buendia, Marie-Annick
    Wei, Yu
    PLOS ONE, 2010, 5 (04):
  • [44] LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression
    Dahan, Jennifer
    Levillayer, Florence
    Xia, Tian
    Nouet, Yann
    Werts, Catherine
    d'Andon, Martine Fanton
    Adib-Conquy, Minou
    Cassard-Doulcier, Anne-Marie
    Khanna, Varun
    Chen, Ju
    Tordjmann, Thierry
    Buendia, Marie-Annick
    Jouvion, Gregory
    Wei, Yu
    MOLECULAR AND CELLULAR BIOLOGY, 2017, 37 (10)
  • [45] The LIM-Only Protein FHL2 is involved in Autophagy to Regulate the Development of Skeletal Muscle Cell
    Liu, Zihao
    Han, Shunshun
    Wang, Yan
    Cui, Can
    Zhu, Qing
    Jiang, Xiaosong
    Yang, Chaowu
    Du, Huarui
    Yu, Chunlin
    Li, Qingyun
    He, Haorong
    Shen, Xiaoxu
    Chen, Yuqi
    Zhang, Yao
    Ye, Lin
    Zhang, Zhichao
    Li, Diyan
    Zhao, Xiaoling
    Yin, Huadong
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (04): : 838 - 846
  • [46] Expression and function of the four and a half LIM-only protein 2 (FHL2) in breast cancer.
    Martin, B. T.
    Kleiber, K.
    Kaufmann, M.
    Strebhardt, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 567S - 567S
  • [47] The LIM-only protein FHL2 is a negative regulator of E4F1
    Paul, C.
    Lacroix, M.
    Iankova, I.
    Julien, E.
    Schaefer, B. W.
    Labalette, C.
    Wei, Y.
    Le Cam, A.
    Le Cam, L.
    Sardet, C.
    ONCOGENE, 2006, 25 (40) : 5475 - 5484
  • [48] Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and β-catenin
    Labalette, C
    Renard, CA
    Neuveut, C
    Buendia, MA
    Wei, Y
    MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (24) : 10689 - 10702
  • [49] Protein-protein interactions of the LIM-only protein FHL2 and functional implication of the interactions relevant in cardiovascular disease
    Tran, M. Khang
    Kurakula, Kondababu
    Koenis, Duco S.
    de Vries, Carlie J. M.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2016, 1863 (02): : 219 - 228
  • [50] The LIM-Only Protein FHL2 Attenuates Lung Inflammation during Bleomycin-Induced Fibrosis
    Alnajar, Abdulaleem
    Nordhoff, Carolin
    Schied, Tanja
    Chiquet-Ehrismann, Ruth
    Loser, Karin
    Vogl, Thomas
    Ludwig, Stephan
    Wixler, Viktor
    PLOS ONE, 2013, 8 (11):